Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway

AIM: Heart failure (HF) post-acute myocardial infarction (AMI) leads to a large number of hospitalizations and deaths worldwide. Danqi pill (DQP) is included in the 2015 national pharmacopoeia and widely applied in the treatment of HF in clinics in China. We examined whether DQP acted on glucose met...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Guo, Dongqing, Wang, Yuanyuan, Wang, Xiaoping, Wang, Qiyan, Wu, Yan, Li, Chun, Wang, Wei, Wang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187888/
https://www.ncbi.nlm.nih.gov/pubmed/32372956
http://dx.doi.org/10.3389/fphar.2020.00458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187888/
https://www.ncbi.nlm.nih.gov/pubmed/32372956
http://dx.doi.org/10.3389/fphar.2020.00458

Ejemplares similares